Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.90 +0.33 (+21.34%)
As of: Oct 2, 2026 · 3:45 PM EDT

Nautilus Biotechnology (NAUT) Non-Current Deffered Revenue (2020 - 2021)

Updated

Nautilus Biotechnology (NAUT) recorded Non-Current Deffered Revenue of $5.23 million in Q1 2021, unchanged from the prior quarter.

Analysis

Nautilus Biotechnology (NAUT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Nautilus Biotechnology 180.66 Mn 180.66 Mn 175,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 5.23 Mn
Dec 31, 2020 5.23 Mn
Sep 30, 2020 5.23 Mn
API Access

Nautilus Biotechnology Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NAUT&period=max&api_key=YOUR_API_KEY